Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-28

Clinical Trial Update: A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

View source ↗

Summary

A completed clinical trial evaluating patients with primary open-angle glaucoma or ocular hypertension who switched to Lumigan UD monotherapy for medical reason…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumigan UD

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2015-05-28